Back to Journals » Drug Design, Development and Therapy » Volume 8

Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely

Total article views   Abstract views HTML views PDF downloads Totals
13,485 Dovepress* 11,431 1,125+ 1,657 12,556
PubMed Central* 2 927 413 929
Totals 11,433 2,052 2,070 13,485
*Since 25 August 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar